H.R. 7473 · 117th Congress
Generic Substitution Noninterference Act
- Stage
- In committee
- Sponsor
- Carolyn Maloney
- Introduced
- 2022-04-07
- Latest action
- 2022-11-01 · Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Summary
Generic Substitution Noninterference Act
This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.